Methods of treating inflammatory and autoimmune diseases with natalizumab Grant US-11333670-B2 United States of America 17 May 2022
Methods of treating inflammatory and autoimmune diseases with natalizumab Grant US-11292845-B2 United States of America 05 Apr 2022